1. Home
  2. CMPS vs LSEA Comparison

CMPS vs LSEA Comparison

Compare CMPS & LSEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CMPS
  • LSEA
  • Stock Information
  • Founded
  • CMPS 2020
  • LSEA 2013
  • Country
  • CMPS United Kingdom
  • LSEA United States
  • Employees
  • CMPS N/A
  • LSEA N/A
  • Industry
  • CMPS Biotechnology: Pharmaceutical Preparations
  • LSEA Homebuilding
  • Sector
  • CMPS Health Care
  • LSEA Consumer Discretionary
  • Exchange
  • CMPS Nasdaq
  • LSEA Nasdaq
  • Market Cap
  • CMPS 246.5M
  • LSEA 222.1M
  • IPO Year
  • CMPS 2020
  • LSEA N/A
  • Fundamental
  • Price
  • CMPS $3.78
  • LSEA $11.22
  • Analyst Decision
  • CMPS Strong Buy
  • LSEA Buy
  • Analyst Count
  • CMPS 6
  • LSEA 4
  • Target Price
  • CMPS $20.20
  • LSEA $13.50
  • AVG Volume (30 Days)
  • CMPS 862.1K
  • LSEA 264.9K
  • Earning Date
  • CMPS 05-08-2025
  • LSEA 05-12-2025
  • Dividend Yield
  • CMPS N/A
  • LSEA N/A
  • EPS Growth
  • CMPS N/A
  • LSEA N/A
  • EPS
  • CMPS N/A
  • LSEA 0.47
  • Revenue
  • CMPS N/A
  • LSEA $1,550,337,000.00
  • Revenue This Year
  • CMPS N/A
  • LSEA N/A
  • Revenue Next Year
  • CMPS N/A
  • LSEA $3.52
  • P/E Ratio
  • CMPS N/A
  • LSEA $13.94
  • Revenue Growth
  • CMPS N/A
  • LSEA 28.13
  • 52 Week Low
  • CMPS $2.49
  • LSEA $5.41
  • 52 Week High
  • CMPS $9.63
  • LSEA $14.04
  • Technical
  • Relative Strength Index (RSI)
  • CMPS 56.88
  • LSEA 85.96
  • Support Level
  • CMPS $3.62
  • LSEA $5.79
  • Resistance Level
  • CMPS $4.03
  • LSEA $7.63
  • Average True Range (ATR)
  • CMPS 0.26
  • LSEA 0.39
  • MACD
  • CMPS -0.01
  • LSEA 0.42
  • Stochastic Oscillator
  • CMPS 38.64
  • LSEA 99.65

About CMPS COMPASS Pathways Plc American Depository Shares

Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.

About LSEA Landsea Homes Corporation

Landsea Homes Corp is a growth-oriented homebuilder focused on providing High-Performance Homes that deliver energy-efficient living in attractive geographies. It is engaged in the design, construction, marketing and sale of suburban and urban single-family detached and attached homes in Arizona, California, Colorado, Florida, Texas, and Metro New York. While It offers a wide range of housing options, it focuses on entry-level and first-time move-up homes and believes its markets are characterized by attractive long-term housing fundamentals. The company's segments include Arizona, California, Colorado, Florida, Metro New York, and Texas. It derives a majority of its revenue from home sales in Florida.

Share on Social Networks: